This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fedorko, J. Articles by Allnoch, H. Search for Related Content PubMed Articles by Fedorko, J. Articles by Allnoch, H. Agricola Articles by Fedorko, J. Articles by Allnoch, H.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1969 November; 18(5): 869-873
Copyright © 1969 American Society for Microbiology. All Rights Reserved.

In Vitro Activity of Coumermycin A₁

Bacteriology Research Laboratory, Veterans Administration Hospital, Washington, D.C. 20422

ABSTRACT

The in vitro activity of coumermycin A₁ was compared with that of novobiocin, ampicillin, and minocycline. Coumermycin was found to be the most active antibiotic of the four against Staphylococcus aureus. It was about 50 times more active than novobiocin or minocycline against the strains tested. Coumermycin also showed good activity against group A streptococci and pneumococci, moderate activity against Escherichia coli, indole-positive Proteus species, and Pseudomonas aeruginosa, and poor activity against Klebsiella-Enterobacter and enterococci. Against P. mirabilis, however, coumermycin activity was almost equal to that of ampicillin. The new antibiotic was further found to be greatly reduced in activity in the presence of plasma, but its minimal inhibitory concentration was not greatly affected by inoculum size. Coumermycin was found to be bacteriostatic in its action, and resistance to it developed slowly. Also, cross-resistance was present with novobiocin but absent with ampicillin or minocycline.